In the the peak year for FDA drug approvals of Joseph V. Gulfo , executive director of the Lewis Center for Healthcare Innovation and Technology at Fairleigh Dickinson University :   Cardiovascular disease remains the number cause of death in the United States , yet , the United States to treat primary cardiovascular disease was approved in 2016 .   Similarly , there were no drugs approved to treat obesity or Alzheimer ’s disease , and just one for diabetes .   These are conditions that are afflicting Americans in epidemic proportions and which cause tremendous morbidity ( sickness ) and mortality ( death ) .As an aside , we can see , once again , the value of a strategy —   a strategy that prioritizes needed categories of cures .   